Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

The purpose of this study is to evaluate the safety and efficacy of LMT1-48(Probiotics) compared to a placebo in reducing the body fat in overweight subjects

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Overweight Body Weight Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

19 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Bundang Hospital

Seongnam-si, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age between 19 and 70 years
Overweight (25 kg/m2 ≤ body mass index (BMI) < 30 kg/m2)

Exclusion criteria

Pregnancy or breast-feeding
Unstable body weight (body weight change > 10% within 3 months before screening)

Treatment and study plan

LMT1-48

Dietary Supplement

capsules containing Probiotics

Placebo

Dietary Supplement

capsules that did not contain any probiotics

Primary outcomes

change from baseline fat percentage at 12 week

Time frame: at baseline and 12-week follow-up

the body composition of the subjects was measured via dual-energy X-ray absorptiometry (DEXA) to determine

Sponsors and collaborators

Lead sponsor

Medy-Tox

Industry

Registry information

Official study title

a Randomised, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject

Important dates

Study start: 2018
Primary completion: 2019
Study completion: 2020
First posted: Nov 30, 2018
Registry last updated: Jul 28, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed